Gallium-68-labeled DOTA-rhenium-cyclized alpha-melanocyte-stimulating hormone analog for imaging of malignant melanoma.
about
Anatomical and molecular imaging of skin cancerPhage display in molecular imaging and diagnosis of cancer.(68)Ga-labeled radiopharmaceuticals for positron emission tomography.Coordinating radiometals of copper, gallium, indium, yttrium, and zirconium for PET and SPECT imaging of diseaseReduction of the ring size of radiolabeled lactam bridge-cyclized alpha-MSH peptide, resulting in enhanced melanoma uptakeTargeted melanoma imaging and therapy with radiolabeled alpha-melanocyte stimulating hormone peptide analoguesGallium-67-labeled lactam bridge-cyclized alpha-melanocyte stimulating hormone peptide for primary and metastatic melanoma imaging.Melanoma imaging using (111)In-, (86)Y- and (68)Ga-labeled CHX-A''-Re(Arg11)CCMSH.Prospective of ⁶⁸Ga-radiopharmaceutical development.Effect of DOTA position on melanoma targeting and pharmacokinetic properties of 111In-labeled lactam bridge-cyclized alpha-melanocyte stimulating hormone peptide.Radiometallated peptides for molecular imaging and targeted therapy.Matching chelators to radiometals for radiopharmaceuticals.Improved synthesis and biological evaluation of chelator-modified α-MSH analogs prepared by copper-free click chemistry.Current advances in ligand design for inorganic positron emission tomography tracers (68)Ga, (64)Cu, (89)Zr and (44)Sc.Radiolabeled peptides: valuable tools for the detection and treatment of cancerExploring new frontiers in molecular imaging: Emergence of Ga PET/CT.Amino acid based gallium-68 chelators capable of radiolabeling at neutral pH.Molecular Imaging and Radionuclide Therapy of Melanoma Targeting the Melanocortin 1 Receptor.PET and SPECT imaging of melanoma: the state of the art.
P2860
Q30476227-815C5E25-43E1-4EA0-B184-127FCBEF75EAQ33532734-05F41B0A-8ADB-41D5-A634-A24476CD4326Q33704038-A314235D-F939-4C09-9F81-43B6D19DC4A1Q33870879-57630FFA-E882-456C-B9DF-9C5ED737E78BQ34386219-2EDDFF5F-6D1E-4158-A1FE-961477AE24B8Q34395062-9CC52295-248D-4797-A001-6144AF3E4000Q34436663-3B9F29FC-20BC-4FB5-BE82-3ED90CD1D6F5Q37364790-76491536-6E2E-4FB1-8FFF-C5043156E12CQ37435222-9F6594CA-A397-4E8B-8909-564682B46CC9Q37450632-742291B9-CBF3-406A-B63D-DA57DDDA929EQ37847064-66EDA303-168B-44BD-97B2-6C4FADF997E5Q38156660-49B65A9B-B484-496C-BA38-9261F0B9F387Q38382330-AA429C25-6D3B-441D-A204-D5656A0393BFQ38729041-3CF6092B-1C81-43B0-B1A8-E7B345D46E0DQ39596344-4DCF1A9A-E7EF-4D52-AB42-ADFE62A905C8Q39805119-91EFB6AB-22C8-4A15-AA91-74F6A1222C1CQ46253893-F94FADFA-6A7E-4A12-8626-8991F18668E2Q47135383-B8342BB2-B343-4040-9507-A9F948DB1177Q47868574-A0610382-344C-4028-A777-D59730EA1DE2
P2860
Gallium-68-labeled DOTA-rhenium-cyclized alpha-melanocyte-stimulating hormone analog for imaging of malignant melanoma.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
Gallium-68-labeled DOTA-rheniu ...... imaging of malignant melanoma.
@ast
Gallium-68-labeled DOTA-rheniu ...... imaging of malignant melanoma.
@en
type
label
Gallium-68-labeled DOTA-rheniu ...... imaging of malignant melanoma.
@ast
Gallium-68-labeled DOTA-rheniu ...... imaging of malignant melanoma.
@en
prefLabel
Gallium-68-labeled DOTA-rheniu ...... imaging of malignant melanoma.
@ast
Gallium-68-labeled DOTA-rheniu ...... imaging of malignant melanoma.
@en
P2093
P2860
P1476
Gallium-68-labeled DOTA-rheniu ...... imaging of malignant melanoma
@en
P2093
Amy L Vāvere
Fabio Gallazzi
Michael J Welch
Thomas P Quinn
Yubin Miao
P2860
P304
P356
10.1016/J.NUCMEDBIO.2007.07.003
P577
2007-09-04T00:00:00Z